Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from
FinraMoving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
Summary:
- Price Zscore is at a recent 2 week low. A recent low ZScore means price drop is accelerating at a record speed.
- Volume Zscore is a recent 2 week high. A recent surge of ZScore means trading activities is accelerating at a record speed.
- Volatility is at a recent 2 week high. A high volatility of stock movement indicates uncertainty.
| MarketCap | 28.9M |
|---|---|
| PE Ratio | |
| PEG Ratio | -0.0 |
| P/B | 1.0 |
| P/S (ttm) | 17.4 |
| Earning Growth (QoQ) | |
| Revenue Growth (QoQ) | |
| Short % | 6% |
| Held by Institutions % | 21% |
| 1 Day Vol Adjusted Return | -3.2 |
| 1 Month Vol Adjusted Return | -4.9 |
| 3 Month Vol Adjusted Return | 3.5 |
| 6 Month Vol Adjusted Return | 2.1 |
| 20 Days SMA Price ZScore | -2.7 |
| 50 Days SMA Price ZScore | -3.0 |
| 12 -26 Days PPO | -4.5 |
| 1 Month Average Short Volume Ratio | 36.7 |
| 1 Day Volume Change ZScore | 4.3 |
| 1 Month Daily Vol | 6.1 |
Stock news
DUBLIN, Ireland and KING OF PRUSSIA, Pa., March 01, 2021 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the commercialization and development of innovative anti-infective agents to treat serious infections, today announced that it has entered into a definitive agreement with certain healthcare-focused and institutional investors for the purchase and sale of (i) an aggregate of 10,361,010 ordinary shares (or pre-funded warrants in lieu thereof)...
DUBLIN, Ireland and KING OF PRUSSIA, Pa., Feb. 26, 2021 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the commercialization and development of innovative anti-infective agents to treat serious infections, today announced the appointment of Daniel Dolan as Chief Financial Officer (CFO), effective close of business March 12, 2021. Mr. Dolan will replace current CFO Gary Sender, who is retiring from Nabriva. Mr. Sender will serve as a consultant...
The Antimicrobials Working Group (AWG) announced today the addition of UTILITY therapeutics Ltd. (UTILITY) to its coalition of companies with the mission to combat drug resistant infections and spur life-saving innovations. This new addition brings AWG's membership to 13 antimicrobial drug companies.
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 1) Abbott Laboratories (NYSE: ABT) Adamas Pharmaceuticals Inc (NASDAQ: ADMS) (announced FDA approval for an expanded indication for its Parkinson's drug) argenx SE – ADR (NASDAQ: ARGX) (announced decision to proceed with the enrollment into the study of subcutaneous efgartigimod in chronic inflammatory demyelinating polyneuropathy) BioCryst Pharmaceutical...
DUBLIN, Ireland and KING OF PRUSSIA, Pa., Feb. 01, 2021 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the commercialization and development of innovative anti-infective agents to treat serious infections, today announced the retirement of Gary Sender as Chief Financial Officer (CFO), effective as of March 12, 2021. Mr. Sender has agreed to serve as a consultant for Nabriva on an ongoing basis following his retirement to ensure business contin...
DUBLIN, Ireland and KING OF PRUSSIA, Pa., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the commercialization and development of innovative anti-infective agents to treat serious infections, today announced that management will participate in two upcoming investor conferences in January. * H.C. Wainwright BioConnect Conference being held virtually from January 11-14, 2021. Ted Schroeder, Chief Executive Officer at Nabriva, wi...